EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)

Clinical trial NCT06531824 · RECRUITING

Trial details

NCT number: NCT06531824
Sponsor: Boehringer Ingelheim
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Kidney Disease, Chronic

Start date: 2024-08-30
Primary completion: 2028-08-30
Enrollment: 11000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.